209 related articles for article (PubMed ID: 19941884)
1. Chronic Delta9-tetrahydrocannabinol during adolescence increases sensitivity to subsequent cannabinoid effects in delayed nonmatch-to-position in rats.
Wiley JL; Burston JJ
Pharmacol Biochem Behav; 2010 Feb; 94(4):516-23. PubMed ID: 19941884
[TBL] [Abstract][Full Text] [Related]
2. (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide.
Järbe TU; Lamb RJ; Lin S; Makriyannis A
Psychopharmacology (Berl); 2001 Aug; 156(4):369-80. PubMed ID: 11498713
[TBL] [Abstract][Full Text] [Related]
3. Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist.
Justinová Z; Ferré S; Redhi GH; Mascia P; Stroik J; Quarta D; Yasar S; Müller CE; Franco R; Goldberg SR
Addict Biol; 2011 Jul; 16(3):405-15. PubMed ID: 21054689
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic augmentation of delta-9-tetrahydrocannabinol (THC) discrimination: possible involvement of D(2)-induced formation of anandamide.
Solinas M; Tanda G; Wertheim CE; Goldberg SR
Psychopharmacology (Berl); 2010 Apr; 209(2):191-202. PubMed ID: 20179908
[TBL] [Abstract][Full Text] [Related]
5. Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects.
Ellgren M; Artmann A; Tkalych O; Gupta A; Hansen HS; Hansen SH; Devi LA; Hurd YL
Eur Neuropsychopharmacol; 2008 Nov; 18(11):826-34. PubMed ID: 18674887
[TBL] [Abstract][Full Text] [Related]
6. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
Falenski KW; Thorpe AJ; Schlosburg JE; Cravatt BF; Abdullah RA; Smith TH; Selley DE; Lichtman AH; Sim-Selley LJ
Neuropsychopharmacology; 2010 Jul; 35(8):1775-87. PubMed ID: 20357755
[TBL] [Abstract][Full Text] [Related]
7. Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.
Solinas M; Scherma M; Tanda G; Wertheim CE; Fratta W; Goldberg SR
J Pharmacol Exp Ther; 2007 Jun; 321(3):1127-34. PubMed ID: 17351107
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
[TBL] [Abstract][Full Text] [Related]
9. Apparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
McMahon LR
Psychopharmacology (Berl); 2009 Apr; 203(2):219-28. PubMed ID: 18592221
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of Δ9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman Primates.
Kangas BD; Leonard MZ; Shukla VG; Alapafuja SO; Nikas SP; Makriyannis A; Bergman J
J Pharmacol Exp Ther; 2016 Apr; 357(1):125-33. PubMed ID: 26826191
[TBL] [Abstract][Full Text] [Related]
11. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological effects of acute and repeated administration of Delta(9)-tetrahydrocannabinol in adolescent and adult rats.
Wiley JL; O'connell MM; Tokarz ME; Wright MJ
J Pharmacol Exp Ther; 2007 Mar; 320(3):1097-105. PubMed ID: 17172531
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats.
Wiley JL; LaVecchia KL; Karp NE; Kulasegram S; Mahadevan A; Razdan RK; Martin BR
Exp Clin Psychopharmacol; 2004 Aug; 12(3):173-9. PubMed ID: 15301634
[TBL] [Abstract][Full Text] [Related]
14. Discriminative stimulus functions of AM-1346, a CB1R selective anandamide analog in rats trained with Delta9-THC or (R)-methanandamide (AM-356).
Järbe TU; Lamb RJ; Liu Q; Makriyannis A
Psychopharmacology (Berl); 2006 Oct; 188(3):315-23. PubMed ID: 16953384
[TBL] [Abstract][Full Text] [Related]
15. Ovarian hormones and chronic administration during adolescence modify the discriminative stimulus effects of delta-9-tetrahydrocannabinol (Δ⁹-THC) in adult female rats.
Winsauer PJ; Filipeanu CM; Bailey EM; Hulst JL; Sutton JL
Pharmacol Biochem Behav; 2012 Sep; 102(3):442-9. PubMed ID: 22705493
[TBL] [Abstract][Full Text] [Related]
16. Dissimilar cannabinoid substitution patterns in mice trained to discriminate Δ(9)-tetrahydrocannabinol or methanandamide from vehicle.
Wiley JL; Matthew Walentiny D; Vann RE; Baskfield CY
Behav Pharmacol; 2011 Sep; 22(5-6):480-8. PubMed ID: 21712709
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of delta 9-THC on spatial reference and working memory in mice.
Varvel SA; Hamm RJ; Martin BR; Lichtman AH
Psychopharmacology (Berl); 2001 Sep; 157(2):142-50. PubMed ID: 11594438
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells.
Hegde VL; Hegde S; Cravatt BF; Hofseth LJ; Nagarkatti M; Nagarkatti PS
Mol Pharmacol; 2008 Jul; 74(1):20-33. PubMed ID: 18388242
[TBL] [Abstract][Full Text] [Related]
19. Previous exposure to delta9-tetrahydrocannibinol enhances locomotor responding to but not self-administration of amphetamine.
Cortright JJ; Lorrain DS; Beeler JA; Tang WJ; Vezina P
J Pharmacol Exp Ther; 2011 Jun; 337(3):724-33. PubMed ID: 21389094
[TBL] [Abstract][Full Text] [Related]
20. Long-term behavioral and pharmacodynamic effects of delta-9-tetrahydrocannabinol in female rats depend on ovarian hormone status.
Winsauer PJ; Daniel JM; Filipeanu CM; Leonard ST; Hulst JL; Rodgers SP; Lassen-Greene CL; Sutton JL
Addict Biol; 2011 Jan; 16(1):64-81. PubMed ID: 21158010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
